Ischemic heart disease

Ischemic Heart Disease — Internal Medicine

How it begins

La cardiopatía isquémica (CI) representa el conjunto de síndromes clínicos derivados de un desequilibrio entre el aporte y la demanda de oxígeno al miocardio, predominantemente causado por obstrucción aterosclerótica de las arterias coronarias.

What it covers

1. Definition and Epidemiology
2. · Definition and Fundamental Concepts
3. · Global and Regional Epidemiology
4. Coronary Atherosclerosis: Pathogenesis
5. · Atherosclerotic Plaque Formation: Atherogenesis
6. · Plaque Rupture, Erosion and Coronary Thrombosis
7. Cardiovascular Risk Factors
8. · Classification and Hierarchy of FRCV
9. · Family Hypercholesterolemia (FH)
10. · Diabetes Mellitus and Cardiovascular Risk
11. Pathophysiology of Myocardial Ischemia
12. · Oxygen Supply-Demand Balance
13. · The Ischemic Cascade
14. · Mechanisms of Cellular Damage due to Ischemia
15. Clinical Classification of Ischemic Heart Disease
16. · Chronic Stable Angina (Chronic Coronary Syndrome)
17. · Acute Coronary Syndromes without ST Elevation (NSTEACS)
18. · Acute ST Elevation Myocardial Infarction (STEMI)
19. Diagnosis
20. · Clinical Evaluation and History
21. · Electrocardiogram (ECG)
22. · Biomarkers of Myocardial Necrosis
23. · Imaging Techniques
24. · Invasive coronary angiography
25. Risk Stratification and Clinical Scores
26. · TIMI score for SCASEST
27. · GRACE score for SCA
28. · Killip-Kimball classification
29. Treatment
30. · Pharmacological Treatment of ACS
31. · Percutaneous Coronary Intervention (PCI)
32. · Coronary Revascularization Surgery (CABG)
33. AMI complications
34. · Mechanical Complications
35. · Electrical Complications
36. · Cardiogenic Shock
37. Cardiac Prevention and Rehabilitation
38. · Secondary Prevention — Fundamental Pillars
39. · Cardiac Rehabilitation (CR)
40. · Implantable Automatic Defibrillator (ICD) in Post-AMI
41. Clinical Pearls and Integration Cases
42. · High Performance Clinical Pearls
43. · Differential Diagnosis Table of Acute Chest Pain
44. · Summary of Therapeutic Objectives in Secondary Prevention